31![Combination therapy targeting ectopic ATP synthase and 26S proteasome induces ER stress in breast cancer cells Combination therapy targeting ectopic ATP synthase and 26S proteasome induces ER stress in breast cancer cells](https://www.pdfsearch.io/img/8c58cc4e18b1c8fa606d2a63e0240549.jpg) | Add to Reading ListSource URL: www.nature.comLanguage: English - Date: 2014-11-27 08:36:24
|
---|
32![Microsoft Word - Publication2004 Microsoft Word - Publication2004](https://www.pdfsearch.io/img/c7f35272400ad4efa4d32b4357468b4f.jpg) | Add to Reading ListSource URL: www.mnc.ust.hkLanguage: English - Date: 2009-07-31 04:22:31
|
---|
33![Preferential Fas-mediated apoptotic execution at G1 phase: the resistance of mitotic cells to the cell death Preferential Fas-mediated apoptotic execution at G1 phase: the resistance of mitotic cells to the cell death](https://www.pdfsearch.io/img/d8f53ddc849d592efc468ddc419467b2.jpg) | Add to Reading ListSource URL: www.nature.comLanguage: English - Date: 2012-05-24 05:56:10
|
---|
34![Microsoft Word - Publication2002 Microsoft Word - Publication2002](https://www.pdfsearch.io/img/a670ea4fcab5c2725cde1923f8fc5c81.jpg) | Add to Reading ListSource URL: www.mnc.ust.hkLanguage: English - Date: 2009-07-31 04:22:31
|
---|
35![CDK-9/cyclin T (P-TEFb) is required in two postinitiation pathways for transcription in the C. elegans embryo Eun Yong Shim,1,2 Amy K. Walker,1,2 Yang Shi,2 and T. Keith Blackwell1,2,3 1 CDK-9/cyclin T (P-TEFb) is required in two postinitiation pathways for transcription in the C. elegans embryo Eun Yong Shim,1,2 Amy K. Walker,1,2 Yang Shi,2 and T. Keith Blackwell1,2,3 1](https://www.pdfsearch.io/img/2c8a2695ab3123710f8b84fd2eb93284.jpg) | Add to Reading ListSource URL: blackwellweb.joslin.harvard.eduLanguage: English - Date: 2003-07-07 15:30:54
|
---|
36![Identification of a Predicted Biologically Effective Dose of AT7519, a Cyclin Dependent Kinase Inhibitor, in a Phase I Study[removed]M. S. Squires1, V. Lock1, J. Adam2 , D. Smith1, N. T. Thompson1, M. Yule1, J. F. Lyons1, Identification of a Predicted Biologically Effective Dose of AT7519, a Cyclin Dependent Kinase Inhibitor, in a Phase I Study[removed]M. S. Squires1, V. Lock1, J. Adam2 , D. Smith1, N. T. Thompson1, M. Yule1, J. F. Lyons1,](https://www.pdfsearch.io/img/51dfcb8fb2490629e4dfa33fc2381a47.jpg) | Add to Reading ListSource URL: astx.comLanguage: English - Date: 2012-12-13 18:06:00
|
---|
37![AT7519, a Selective Small Molecule Inhibitor of Cyclin Dependent Kinases: Pharmacodynamic Biomarker Activity in a Phase I Study. Author(s) MS Squires, PJ Sweeney, V Lock, NT Thompson, D Smith, EJ Lewis, NJ Gallagher, H C AT7519, a Selective Small Molecule Inhibitor of Cyclin Dependent Kinases: Pharmacodynamic Biomarker Activity in a Phase I Study. Author(s) MS Squires, PJ Sweeney, V Lock, NT Thompson, D Smith, EJ Lewis, NJ Gallagher, H C](https://www.pdfsearch.io/img/3a216476733f659114306c5e0531f552.jpg) | Add to Reading ListSource URL: astx.comLanguage: English |
---|
38![AT7519, a Potent Multi-targeted CDK Inhibitor, is Active in CLL Patient Samples Independent of Stage 3161 V Lock1, L Cooke2, M Yule1, NT Thompson1, K Della Croce2, JF Lyons1,MS Squires1,D Mahadevan2. INTRODUCTION AT7519, a Potent Multi-targeted CDK Inhibitor, is Active in CLL Patient Samples Independent of Stage 3161 V Lock1, L Cooke2, M Yule1, NT Thompson1, K Della Croce2, JF Lyons1,MS Squires1,D Mahadevan2. INTRODUCTION](https://www.pdfsearch.io/img/1a9fde0f60547d8f5d3a76c450c0fbd4.jpg) | Add to Reading ListSource URL: astx.comLanguage: English |
---|
39![OPEN Citation: Cell Death and Disease[removed], e693; doi:[removed]cddis[removed] & 2013 Macmillan Publishers Limited All rights reserved[removed]www.nature.com/cddis OPEN Citation: Cell Death and Disease[removed], e693; doi:[removed]cddis[removed] & 2013 Macmillan Publishers Limited All rights reserved[removed]www.nature.com/cddis](https://www.pdfsearch.io/img/3225740b046d9d54422960f054895f56.jpg) | Add to Reading ListSource URL: www.nature.comLanguage: English - Date: 2013-06-27 09:56:01
|
---|
40![ABSTRACT # 491 NCIC CTG IND.177: Phase I Study of AT7519M Given as a Short Infusion Twice Weekly S. J. Hotte, E. X. Chen, L. McIntosh, H. Hirte, S. Turner, A. Jarvi, V. Lock, L. Seymour ABSTRACT # 491 NCIC CTG IND.177: Phase I Study of AT7519M Given as a Short Infusion Twice Weekly S. J. Hotte, E. X. Chen, L. McIntosh, H. Hirte, S. Turner, A. Jarvi, V. Lock, L. Seymour](https://www.pdfsearch.io/img/ea475d538937c3f464507ee213c01f8c.jpg) | Add to Reading ListSource URL: astx.comLanguage: English - Date: 2012-12-13 18:06:00
|
---|